BioGaia

Board/Management Information • Dec 8, 2009

Press Release 8 December 2009

BioGaia nominates two Executive Vice Presidents

The board of BioGaia has nominated Margareta Hagman and Urban Strindlöv as Executive Vice Presidents of the company as of April 1, 2010. Margareta is responsible for accounting, finance and administration whilst Urban is responsible for product development and special projects.

Latest press releases from BioGaia:

2009-10-22 Interim report 1 January – 30 September 2009 2009-10-08 BioGaia agreement for Denmark 2009-09-18 BioGaia signs agreement for France

For additional information contact:

Peter Rothschild, President, telephone: +46 8 -555 293 00 Jan Annwall, Executive Vice President, telephone: +46 8-555 293 00

BioGaia is a biotechnology company that develops, markets and sells probiotic products with documented health benefits. The products are primarily based on the lactic acid bacterium Lactobacillus reuteri (Reuteri), which has probiotic, health-enhancing effects. The class B share of the Parent Company BioGaia AB is quoted on the Small Cap list of the NASDAQ OMX Nordic Exchange Stockholm. www.biogaia.com